Atovaquone/Proguanil

BreastfeedingGeriatric
  • TRADE NAME: Malarone (GSK)
  • INDICATIONS: Malaria prophylaxis and treatment
  • CLASS: Antimalarial
  • HALF-LIFE: 24 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Artemether/Lumefantrine, Dapsone, Etoposide, Hypoglycemic agents, Indinavir, Metoclopramide, Phenothiazines, Rifabutin, Rifampin, Ritonavir, Tetracycline, Typhoid Vaccine

PREGNANCY CATEGORY: C

Our database has 28 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top